Celon Pharma S.A.
Researches, develops, and markets innovative drugs for oncology and neurology.
CLN | WAR
Overview
Corporate Details
- ISIN(s):
- PLCLNPH00015 (+3 more)
- LEI:
- 259400Q0ERJT0NC5DT24
- Country:
- Poland
- Address:
- KAZUŃ NOWY MARYMONCKA 15, 05-152 KAZUŃ NOWY
- Website:
- https://celonpharma.com/en/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Celon Pharma S.A. is an integrated biopharmaceutical company engaged in the research, development, manufacturing, and marketing of modern drugs. Established in 2002, the company focuses on creating innovative therapeutic solutions. Its research and development pipeline concentrates on treatments for neurological diseases, such as Parkinson's disease, and oncology. As a marketing authorization holder, Celon Pharma manages the entire product lifecycle, from advanced scientific discovery and clinical trials to full-scale production and commercialization. The company aims to provide therapies that improve the quality and length of patients' lives.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-11-19 17:13 |
Regulatory News Service
Raport 3 kwartał 2025
|
Polish | 2.3 MB | ||
| 2025-10-10 15:36 |
Registration Form
Statut - tekst jednolity
|
Polish | 405.4 KB | ||
| 2025-10-10 15:36 |
Registration Form
Rejestracja zmiany Statutu Spółki - Content (PL)
|
Polish | 1.7 KB | ||
| 2025-10-03 17:06 |
Regulatory News Service
Zawarcie przez spółkę zależną umowy z generalnym wykonawcą inwestycji - Content…
|
Polish | 2.7 KB | ||
| 2025-10-02 17:55 |
Legal Proceedings Report
Podsumowanie spotkania z Food and Drug Administration, (FDA) typu B dla CPL'36…
|
English | 3.4 KB | ||
| 2025-10-02 17:55 |
Legal Proceedings Report
Podsumowanie spotkania z Food and Drug Administration, (FDA) typu B dla CPL'36…
|
Polish | 3.2 KB | ||
| 2025-09-17 17:55 |
Audit Report / Information
Raport z przeglądu
|
Polish | 218.2 KB | ||
| 2025-09-17 17:55 |
Audit Report / Information
Raport z przeglądu
|
Polish | 437.5 KB | ||
| 2025-09-17 17:55 |
Management Discussion and Analysis
Sprawozdanie z działalności Zarządu
|
Polish | 953.2 KB | ||
| 2025-09-17 17:55 |
Interim Report
Sprawozdanie finansowe H12025
|
Polish | 1.6 MB | ||
| 2025-09-11 11:12 |
Report Publication Announcement
Aktualizacja informacji dotyczącej przekazywania raportów okresowych w 2025 rok…
|
Polish | 1.9 KB | ||
| 2025-08-04 15:16 |
Capital/Financing Update
Uzgodnienie z Europejskim Bankiem Odbudowy i Rozwoju głównych warunków udzielen…
|
Polish | 1.5 KB | ||
| 2025-07-16 21:15 |
Major Shareholding Notification
zal01_TCM_Celon_Notification_Form.pdf
|
English | 89.7 KB | ||
| 2025-07-16 21:15 |
Major Shareholding Notification
Otrzymanie zawiadomienia o przekroczeniu progu 5% udziału w ogólnej liczbie gło…
|
Polish | 1.1 KB | ||
| 2025-06-26 21:39 |
Post-Annual General Meeting Information
Wykaz akcjonariuszy posiadających co najmniej 5% głosów na Zwyczajnym Walnym Zg…
|
Polish | 888 bytes |
Automate Your Workflow. Get a real-time feed of all Celon Pharma S.A. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Celon Pharma S.A.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Celon Pharma S.A. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
